Talk:Assessment of the health impacts of H1N1 vaccination/Group B

From Opasnet
< Talk:Assessment of the health impacts of H1N1 vaccination
Revision as of 21:03, 31 March 2011 by Jouni (talk | contribs) (Created page with "Category:DARM exercise == Pandemrix should not be used because of narcolepsy risk == {{discussion |Statements= Pandemrix should not be used any more anywhere because its nar...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Pandemrix should not be used because of narcolepsy risk

How to read discussions

Fact discussion: .
Opening statement: Pandemrix should not be used any more anywhere because its narcolepsy risk is too high. NOTE! The time of the statement is September 2010.

Closing statement: Resolution not yet found.

(A closing statement, when resolved, should be updated to the main page.)

Argumentation:

⇤--1: . Despite risks, Pandemrix is an effective vaccine and has clearly net positive effects in countries where emergency treatment is poorly available for severe swine flu cases. --Jouni 23:05, 31 March 2011 (EEST) (type: truth; paradigms: science: attack)

←--2: . The reputation of Pandemrix is globally so poor that it is impossible to use it any more. --Jouni 23:05, 31 March 2011 (EEST) (type: truth; paradigms: science: defence)

←--3: . In Finland, THL decided to stop the use of Pandemrix. --Jouni 23:05, 31 March 2011 (EEST), [1] (type: truth; paradigms: science: defence)
Retrieved from "https://en.opasnet.org/index.php?title=Talk:Assessment_of_the_health_impacts_of_H1N1_vaccination/Group_B&oldid=19775"